<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">Metastasis</z:e> is the most frequent cause of treatment failure and <z:hpo ids='HP_0011420'>death</z:hpo> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Early detection of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> is crucial for improving treatment strategies and patient outcome </plain></SENT>
<SENT sid="2" pm="."><plain>Development of reliable biomarkers and simple tests routinely applicable in the clinic for detection, prognostication, and therapy monitoring is of special interest </plain></SENT>
<SENT sid="3" pm="."><plain>We recently identified the novel gene <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">Metastasis</z:e>-Associated in <z:hpo ids='HP_0003003'>Colon Cancer</z:hpo> 1 (MACC1), a key regulator of the HGF/Met-pathway </plain></SENT>
<SENT sid="4" pm="."><plain>MACC1 is a strong prognostic biomarker for <z:hpo ids='HP_0003003'>colon cancer</z:hpo> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and allows identification of high-risk subjects in early stages, when determined in patients' <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>To overcome the limitation of a restricted number of molecular analyses in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue, the establishment of a non-invasive blood test for early identification of <z:e sem="disease" ids="C1512441" disease_type="Neoplastic Process" abbrv="">high-risk cancer</z:e> patients, for monitoring disease course and therapy response is strongly needed </plain></SENT>
<SENT sid="6" pm="."><plain>METHODOLOGY/PRINCIPAL FINDINGS: For the first time, we describe a non-invasive assay for quantification of circulating MACC1 transcripts in blood of more than 300 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients </plain></SENT>
<SENT sid="7" pm="."><plain>MACC1 transcript levels are increased in <z:hpo ids='HP_0000001'>all</z:hpo> disease stages of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients compared to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-free volunteers </plain></SENT>
<SENT sid="8" pm="."><plain>Highest MACC1 levels were determined in individuals with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> (<z:hpo ids='HP_0000001'>all</z:hpo> P&lt;0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>Importantly, high MACC1 levels correlate with unfavorable survival (P&lt;.0001) </plain></SENT>
<SENT sid="10" pm="."><plain>Combining MACC1 with circulating transcripts of the <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> gene S100A4, a transcriptional target of the Wnt/Î²-catenin-pathway, improves survival prediction for newly diagnosed <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION/SIGNIFICANCE: This blood-based assay for circulating MACC1 transcripts, which can be quantitated on a routine basis, is clinically applicable for diagnosis, prognosis, and therapeutic monitoring of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients </plain></SENT>
<SENT sid="12" pm="."><plain>Here we demonstrate the diagnostic and prognostic value of circulating MACC1 transcripts in patient plasma for <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and survival </plain></SENT>
<SENT sid="13" pm="."><plain>Since MACC1 represents a promising target for anti-metastatic therapies, circulating MACC1 transcripts may prove to be an ideal read-out for monitoring therapeutic response of future interventions targeting MACC1-induced <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients </plain></SENT>
</text></document>